Literature DB >> 33926105

Autoinflammatory Features in Gouty Arthritis.

Paola Galozzi1, Sara Bindoli1, Andrea Doria1, Francesca Oliviero1, Paolo Sfriso1.   

Abstract

In the panorama of inflammatory arthritis, gout is the most common and studied disease. It is known that hyperuricemia and monosodium urate (MSU) crystal-induced inflammation provoke crystal deposits in joints. However, since hyperuricemia alone is not sufficient to develop gout, molecular-genetic contributions are necessary to better clinically frame the disease. Herein, we review the autoinflammatory features of gout, from clinical challenges and differential diagnosis, to the autoinflammatory mechanisms, providing also emerging therapeutic options available for targeting the main inflammatory pathways involved in gout pathogenesis. This has important implication as treating the autoinflammatory aspects and not only the dysmetabolic side of gout may provide an effective and safer alternative for patients even in the prevention of possible gouty attacks.

Entities:  

Keywords:  IL-1 inhibitors; autoinflammation; gout; therapy

Year:  2021        PMID: 33926105     DOI: 10.3390/jcm10091880

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  80 in total

1.  Annexin A1 promotes timely resolution of inflammation in murine gout.

Authors:  Izabela Galvão; Juliana P Vago; Livia C Barroso; Luciana P Tavares; Celso M Queiroz-Junior; Vivian V Costa; Fernanda S Carneiro; Tatiana P Ferreira; Patricia M R Silva; Flávio A Amaral; Lirlândia P Sousa; Mauro M Teixeira
Journal:  Eur J Immunol       Date:  2017-01-12       Impact factor: 5.532

2.  Replication of association of the apolipoprotein A1-C3-A4 gene cluster with the risk of gout.

Authors:  Humaira Rasheed; Amanda J Phipps-Green; Ruth Topless; Malcolm D Smith; Catherine Hill; Susan Lester; Maureen Rischmueller; Matthijs Janssen; Timothy L Jansen; Leo A Joosten; Timothy R Radstake; Philip L Riches; Anne-Kathrin Tausche; Frederic Lioté; Alexander So; Andre van Rij; Gregory T Jones; Sally P McCormick; Andrew A Harrison; Lisa K Stamp; Nicola Dalbeth; Tony R Merriman
Journal:  Rheumatology (Oxford)       Date:  2016-04-18       Impact factor: 7.580

3.  Management of Gout-associated MSU crystals-induced NLRP3 inflammasome activation by procyanidin B2: targeting IL-1β and Cathepsin B in macrophages.

Authors:  Chun-Ying Qiao; Ying Li; Yue Shang; Min Jiang; Jian Liu; Zi-Ying Zhan; Huan Ye; Yong-Ce Lin; Jing-Ya Jiao; Rong-Hui Sun; Zhi-Hong Zhang; Mei-Hua Piao; Yan-Ling Wu; Ji-Xing Nan; Li-Hua Lian
Journal:  Inflammopharmacology       Date:  2020-10-01       Impact factor: 4.473

4.  LncRNA ANRIL promotes NLRP3 inflammasome activation in uric acid nephropathy through miR-122-5p/BRCC3 axis.

Authors:  Jiacai Hu; Hao Wu; Daochun Wang; Zhijie Yang; Junjun Dong
Journal:  Biochimie       Date:  2018-10-19       Impact factor: 4.079

5.  Rapid induction of peroxisome proliferator-activated receptor gamma expression in human monocytes by monosodium urate monohydrate crystals.

Authors:  Tohru Akahoshi; Rie Namai; Yousuke Murakami; Megumi Watanabe; Toshimichi Matsui; Akito Nishimura; Hidero Kitasato; Toru Kameya; Hirobumi Kondo
Journal:  Arthritis Rheum       Date:  2003-01

6.  The polymorphism -863C/A in tumour necrosis factor-alpha gene contributes an independent association to gout.

Authors:  S-J Chang; P-C Tsai; C-J Chen; H-M Lai; Y-C Ko
Journal:  Rheumatology (Oxford)       Date:  2007-10-15       Impact factor: 7.580

7.  Single nucleotide polymorphisms associated with P2X7R function regulate the onset of gouty arthritis.

Authors:  Jin-Hui Tao; Miao Cheng; Jiang-Ping Tang; Xiao-Juan Dai; Yong Zhang; Xiang-Pei Li; Qin Liu; Ya-Ling Wang
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

8.  Invariant Natural Killer T Cells Ameliorate Monosodium Urate Crystal-Induced Gouty Inflammation in Mice.

Authors:  Jie Wang; Qibin Yang; Quanbo Zhang; Congcong Yin; Li Zhou; Jingguo Zhou; Yangang Wang; Qing-Sheng Mi
Journal:  Front Immunol       Date:  2017-12-12       Impact factor: 7.561

9.  Decreased Expression of CD14 in MSU-Mediated Inflammation May Be Associated with Spontaneous Remission of Acute Gout.

Authors:  Lihua Duan; Jiao Luo; Qiang Fu; Ke Shang; Yingying Wei; Youlian Wang; Yan Li; Jie Chen
Journal:  J Immunol Res       Date:  2019-06-13       Impact factor: 4.818

10.  Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis.

Authors:  Shrikant R Mulay; Jyaysi Desai; Santhosh V Kumar; Jonathan N Eberhard; Dana Thomasova; Simone Romoli; Melissa Grigorescu; Onkar P Kulkarni; Bastian Popper; Volker Vielhauer; Gabriele Zuchtriegel; Christoph Reichel; Jan Hinrich Bräsen; Paola Romagnani; Rostyslav Bilyy; Luis E Munoz; Martin Herrmann; Helen Liapis; Stefan Krautwald; Andreas Linkermann; Hans-Joachim Anders
Journal:  Nat Commun       Date:  2016-01-28       Impact factor: 14.919

View more
  13 in total

Review 1.  Promising Strategies for Transdermal Delivery of Arthritis Drugs: Microneedle Systems.

Authors:  Jitong Wang; Jia Zeng; Zhidan Liu; Qin Zhou; Xin Wang; Fan Zhao; Yu Zhang; Jiamiao Wang; Minchen Liu; Ruofei Du
Journal:  Pharmaceutics       Date:  2022-08-19       Impact factor: 6.525

2.  The interplay between HLA-B and NLRP3 polymorphisms may be associated with the genetic susceptibility of gout.

Authors:  Javier Fernández-Torres; Gabriela Angélica Martínez-Nava; Karina Martínez-Flores; Roberto Sánchez-Sánchez; Luis J Jara; Yessica Zamudio-Cuevas
Journal:  Mol Biol Rep       Date:  2022-09-03       Impact factor: 2.742

Review 3.  IL-1 and autoinflammatory disease: biology, pathogenesis and therapeutic targeting.

Authors:  Lori Broderick; Hal M Hoffman
Journal:  Nat Rev Rheumatol       Date:  2022-06-21       Impact factor: 32.286

4.  Alteration of Gut Microbiome and Correlated Amino Acid Metabolism Contribute to Hyperuricemia and Th17-Driven Inflammation in Uox-KO Mice.

Authors:  Siyue Song; Yu Lou; Yingying Mao; Xianghui Wen; Moqi Fan; Zhixing He; Yang Shen; Chengping Wen; Tiejuan Shao
Journal:  Front Immunol       Date:  2022-02-07       Impact factor: 7.561

5.  Tongbixiao Pills Improve Gout by Reducing Uric Acid Levels and Inhibiting Inflammation.

Authors:  Shijun Xi; Lu Li; Zhuang Gui; Peng Liu; Qi Jiang; Yuan Yu; Wen Zhou; Ziqi Zhou; Shuo Zhang; Xiao Chun Peng; Bo Su
Journal:  Dose Response       Date:  2022-04-09       Impact factor: 2.658

6.  Editorial: Advances in Pathogenesis and Therapies of Gout.

Authors:  Lihua Duan; Jixin Zhong; Ye Yang; Xiaoxia Zhu
Journal:  Front Immunol       Date:  2022-04-01       Impact factor: 8.786

7.  Regulatory Role of miRNAs and lncRNAs in Gout.

Authors:  Jianlong Shu; Minhua Chen; Chunse Ya; Ruixia Yang; Fengzhen Li
Journal:  Comput Math Methods Med       Date:  2022-06-29       Impact factor: 2.809

8.  Potential molecular mechanisms of Ermiao san in the treatment of hyperuricemia and gout based on network pharmacology with molecular docking.

Authors:  Yin-Hong Geng; Jia-Hui Yan; Liang Han; Zhe Chen; Sheng-Hao Tu; Lin-Qi Zhang; Chun-Dong Song; Feng-Yang Duan; Ya-Fei Liu
Journal:  Medicine (Baltimore)       Date:  2022-09-16       Impact factor: 1.817

9.  Clinical Features and Risk Factors of Fever in Acute Gouty Arthritis.

Authors:  Yan Huang; Meiju Zhou; Fang Yuan
Journal:  Biomed Res Int       Date:  2022-10-03       Impact factor: 3.246

10.  Inflammation-Driven Secretion Potential Is Upregulated in Osteoarthritic Fibroblast-Like Synoviocytes.

Authors:  Jakub Chwastek; Marta Kędziora; Małgorzata Borczyk; Michał Korostyński; Katarzyna Starowicz
Journal:  Int J Mol Sci       Date:  2022-10-05       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.